• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Rabbit polyclonal to LPA receptor 1

Prasugrel (CS-747 LY640315) is a novel member of the thienopyridine class

August 21, 2017 by Katherine Lewis Leave a Comment

Prasugrel (CS-747 LY640315) is a novel member of the thienopyridine class of oral anti-platelet Rabbit polyclonal to LPA receptor 1 brokers (also including ticlopidine and clopidogrel). studies in patients with cardiovascular disease confirmed the greater efficacy of prasugrel compared with clopidogrel. Collectively these PF-03814735 phase 1/1b studies and a phase 2 study PF-03814735 (JUMBO-TIMI 26) … [Read more…]

Posted in: Blogging Tagged: Rabbit polyclonal to LPA receptor 1

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by